Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in first-quarter 2025 from ...

The global dermatological cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...

US biotech Jazz Pharmaceuticals (Nasdaq: JAZZ) is banking on continued growth from Epidiolex (cannabidiol), the first ...

The US Department of Health and Human Services has announced a sweeping change to the way new vaccines are evaluated, saying ...

Anglo-Swedish pharma major AstraZeneca has presented positive top-line results from the Phase III KALOS and LOGOS trials in ...

US biotech major Amgen (Nasdaq AMGN) late Thursday announced financial results for the first quarter of 2025, revealing that ...

The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by ...

Cidara Therapeutics, a San Diego biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) ...

Shares in Kronos Bio, a US biotech that has been developing small molecule therapeutics to address cancers and other diseases ...